Literature DB >> 10526056

Cellular kinetics and gene mutations in gallbladder mucosa with an anomalous junction of pancreaticobiliary duct.

K Hanada1, A Tsuchida, G Kajiyama.   

Abstract

Anomalous junction of the pancreaticobiliary duct (AJPBD) is thought to be an important risk factor for gallbladder carcinoma in Japan. We have reported the characteristic pathology, cellular kinetics, and gene mutations to clarify the mechanism of carcinogenesis in gallbladder mucosa with AJPBD. A comprehensive review of the literature was undertaken, with referencing of major articles on the subject. A sequence of hyperplastic changes, with a corresponding increase in cellular kinetics with progression through dysplasia to carcinoma is important in carcinogenesis of gallbladder mucosa with AJPBD. p53 mutations may contribute to the transition from premalignancy to malignancy in the early stage of carcinogenesis of the gallbladder mucosa, regardless of the presence of AJPBD. The specific mutation of GGT-to-GAT in codon 12 of K-ras may play an important role in carcinogenesis of gallbladder mucosa with AJPBD.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10526056     DOI: 10.1007/s005340050111

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  8 in total

Review 1.  Pancreaticobiliary reflux in patients with a normal pancreaticobiliary junction: Pathologic implications.

Authors:  Marcelo A Beltrán
Journal:  World J Gastroenterol       Date:  2011-02-28       Impact factor: 5.742

2.  Pancreaticobiliary reflux as a high-risk factor for biliary malignancy: Clinical features and diagnostic advancements.

Authors:  Reiji Sugita
Journal:  World J Hepatol       Date:  2015-07-08

3.  Regional differences in gallbladder cancer pathogenesis: insights from a comparison of cell cycle-regulatory, PI3K, and pro-angiogenic protein expression.

Authors:  Jean M Butte; Javiera Torres; Emanuela F Veras; Kenichi Matsuo; Mithat Gönen; Michael I D'Angelica; Enrique Waugh; Manuel Meneses; Yoshiyaki Inayama; Yuman Fong; Ronald P Dematteo; Hernan De La Fuente; Itaru Endo; David S Klimstra; William R Jarnagin
Journal:  Ann Surg Oncol       Date:  2012-12-01       Impact factor: 5.344

4.  Clinicopathologic Differences in Patients with Gallbladder Cancer According to the Presence of Anomalous Biliopancreatic Junction.

Authors:  Jihoon Chang; Jin-Young Jang; Mee Joo Kang; Woohyun Jung; Yong Chan Shin; Sun-Whe Kim
Journal:  World J Surg       Date:  2016-05       Impact factor: 3.352

5.  The effects of miR-1207-5p expression in peripheral blood on cisplatin-based chemosensitivity of primary gallbladder carcinoma.

Authors:  Er-Dong Shen; Bo Liu; Xin-Shuang Yu; Zhen-Fei Xiang; Hui-Yun Huang
Journal:  Onco Targets Ther       Date:  2016-06-20       Impact factor: 4.147

Review 6.  Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update.

Authors:  Aarti Sharma; Kiran Lata Sharma; Annapurna Gupta; Alka Yadav; Ashok Kumar
Journal:  World J Gastroenterol       Date:  2017-06-14       Impact factor: 5.742

Review 7.  A genetic model for gallbladder carcinogenesis and its dissemination.

Authors:  S G Barreto; A Dutt; A Chaudhary
Journal:  Ann Oncol       Date:  2014-04-04       Impact factor: 32.976

8.  Diagnosis of distal cholangiocarcinoma after the removal of choledocholithiasis.

Authors:  Yasuhiro Ito; Takeshi Kenmochi; Tomohisa Egawa; Shinobu Hayashi; Atsushi Nagashima; Yuko Kitagawa
Journal:  Gastroenterol Res Pract       Date:  2012-11-22       Impact factor: 2.260

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.